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ABSTRACT 
Serum ionized calcium has Ions been viewed as the 
Phwsiolosicallw active form of calciumr wet the Paucitw of 
studies concerned with this response measure is apparent and 
maw be related to the hiSh cost of modern Potentiometric 
instrumentation. Reducing the cost factor was approached bw 
integrating an inexpensive static-twPe calcium ion-specific 
electrode into a fabricated Plastic electrode chamber. 
Characterization of the electrode swstem was Performed b~ 
elucidating the optimum Parameters for electrode use in 
serum samples. Conformance to the extended 
Nicolskw-Eisenman eGuation was. used as a criterion for 
acceptable electrode swstem Performance. Negligable effects 
of Proteins on the Performance of the electrode was 
established bw comparing calcium binding kinetics and PH 
dePendence data obtained with 
obtained from the literature. 
the 
The 
swstem with values 
electrode s~stem was 
shown to correlate well when compared with the Orion SS-20 
serum ionized calcium instrument with over 97% of the 
variance accounted for bw resression. The administration of 
calcium chloride or the divalent cation chelatorr eth~lene 
diamine tetraacetic acidr to rats resulted in Predictable 
responses in serum ionized calcium. 
The serum ionized calcium electrode swstem was emplowed 
in tests of hwPotheses concerning serum ionized calcium and 
antidepressant activity of the tricYclic antidepressant, 
ProtriPtYline and the thyroid hormone' tri-iodothYronine. 
Rats treated with ProtriPtYline (10ms/ks> for 1, 6 or 18 
days and tested 2, 6, 12 and 24 hours after the last dose 
failed to show sisnificant chanses in serum ionized calcium. 
Similarly, animals treated with tri-iodothYronine at varYins 
doses for 1, 5 or 10 days and tested 1, 4 or 24 hours after 
the last dose also failed to show chanses in this response 
measure. Concomitant thyroid hormone at varYins doses and 
ProtriPtYline (5ms/kg) did not result in chanses in serum 
ionized calcium or in any response measures studied which 
are either known or are ~usPected to be reflective of 
chanses in calcium homeostasis. The results failed to 
suPPort a calcium hYPothesis of antidepressant activity. 
The results are at variance with those of clinical 
studies amons depressives reported in the literature. 
Discussion offers support for viewins the rat as a Poor 
animal model for studYins alterations in calcium 
homeostasis. 
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PREFACE 
• This thesis is Presented in the manuscript format 
accordins to the rules of the Graduate School of the 
Universitw of Rhode Island. Two manuscripts are included. 
I. An Inexpensive Method for the Determination 
of Serum Ionized Calcium 
II. Mechanisms of Antidepressant Action: Uptake 
Blockade or Serum Ionized Calcium 
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INTRODUCTION 
Serum ionized calcium has lons been viewed as the 
PhYsiologicallY active form of calcium (20) but the 
laborious techniGues reGuired for its determination have 
limited both clinical and experimental studies. In 1967, 
Ross (21) introduced the calcium ion-specific electrode 
<ISE> and a short time thereafter Orion Research' Inc. made 
available a flow-through calcium ISE designed to measure 
ionized calcium in biological fluids anaerobically. This 
moderately Priced electrode is no longer available and was 
replaced by a much more expensive microprocessor-controlled 
apparatus. Although other sophisticated instruments are 
commercially available, it aPPears that the Paucity of 
literature concerning serum ionized calcium maY be a direct 
result of the high cost of instrumentation. 
Reducing the cost factor was approached b~ intesrating 
an inexpensive static-type calcium ISE into an easil~ 
fabricated Plastic electrode chamber to Permit 
temperature-controlled, anaerobic samPling <0.6 ml) with the 
aid of commonly available laboratory eGuiPment includins a 
sensitive PH/mV meter and a circulating water bath. Since 
the static-type ISE is not recommended for use with serum 
samples' this report includes a characterization and 
aPPlication for such use. Also included are the 
construction details of the electrode chamber. 
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MATERIALS AND METHODS 
aeearaius The Potentiometric components of the experimental 
aPParatus, obtained frbm Orion Research' Inc. <Cambridge, 
Mass.), include an electrode bod~ (model 93- 00> attached to 
a calcium ISE sensins module <model 93-20> and a sinsle 
Junction reference electrode <model 93-01) utilizins 4M KCl 
saturated with silver as the internal fillinS solution. The 
electrode Potential was measured with an Orion disital PH/mV 
meter <model 701A> in the relative mV mode. Sample 
temperature was controlled b~ circulating water through the 
Plastic samPling chamber using a constant temperature 
circulatins PumP <HETO, Denmark; model 7402). 
Serum PH was measured usins a blood Sas anal~zer <IL 
model 413). 
Samelios Cbamber = Coosiruciioo Deiails The Plastic chamber 
was constructed of Plexislas<R> with critical dimensions 
denoted in the Pictorial representations (figures 1 and 2>. 
A PhotosraPh of the assembled apparatus is shown in fisure 
3. 
The Plastic was cut to the reouired sizes indicated in 
table 1. Sides of the UPPer and lower assembl~ were fitted 
with 1/8• male hose adapters <Cole-Palmer; Chicago, I l • > • 
Holes for the electrode bodies were drilled usins a spade 
PAGE 4 
bit (5/8•> while the toP and bottom Plates of the UPPer 
assemblw were held tosether to insure proper hole alisnment. 
The bottom Plate of the UPPer assemblw forms a maJor 
Part of the sample compartment. Sample entrw and exit Ports 
were made bw drillins 1/16• channels obliauelw from the 
center of the front and back edses to near the bottom of the 
electrode bodw holes. A 1/16• troush was created bw filins 
the underside of the bottom Plate between the electrode bodw 
holes. Threaded ends of female Instac<R> Luer-Boss adapters 
<Lee Co.; Westbrook, Ct.> were sround off, and the 
resultant flat surface sanded lishtlw. These adapters were 
components of the sample entrw and exit Ports. Thew were 
fitted over the channels' secured into Position with a drop 
of methwlene chloride and further reinforced with a bead of 
ePoxw cement. 
The electrode chamber was assembled and held in 
Position with elastic bands. Methwlene chloride was aPPlied 
to all contactins surfaces with the aid of a slass swrinse 
and stainless steel needle. UPon removal of the elastic 
bands, successive aPPlications of Plastic shavinss dissolved 
in methwlene chloride (5% and then 15% w/v) were made to 
Provide leak-Proof seals. 
The electrodes were inserted into the holes and secured 
into Position with 112• x 1/16• Buna-N 0-rinss <Arthur H. 
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Thomas Co.~ Phila., Pa.). A sheet of teflon served as the 
remainins Part of the samPle compartment. The distance 
between the active surface of the electrodes and the teflon 
sheet, alons with the Position of the 0-rinss, determined 
the sample volume reauired for analysis. Generally, 0.6 ml 
was reauired to comPletelY fill the sample compartment. The 
teflon was backed with cork sheetins and the lower assembly, 
corkr teflon sheet and UPPer assembly were all held tosether 
with steel rods and turnbuckles (fisure 3>. 
Use of tbe Samelios Cbambe~ The assembled electrode chamber 
was oriented at 45 desrees with respect to the sample entry 
Port and a vertical Plane. This orientation Prevented air 
from becomins trapped within the sample comPartment. The 
sample was introduced into the sample compartment with a 
SY rinse. The exit Port was capped with a Leur-Lock end cap 
when the sample besan to emerse from the Port. The chamber 
was flushed 3 times with 3 ml of isotonic saline between the 
introduction of samples and standards. 
Reasects All chemicals were of reasent srade <Fisher 
Scientific, Pa.> and solutions were Prepared with 
distilled - deionized water. Standards were Prepared from 
stock solutions <M> of NaCl <4.0), KCl <0.5), MsC1 2 <0.55), 
CaC03 <O.l> dissolved in HCl <0.24), CaC1 2 <0.1), HCl <1.0> 
and NaOH <1.0>. Tris-(hydroxymethyl)-aminomethane CTRISr 
1.0> and disodiu~ ethYlenediamine tetraacetic acid <EDTA, 
0.05> was Purchased from Sigma Chemical Co. 
Mo.>. 
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(St. Louis, 
Calculaiioos A> Ionic strength- In the Preparation of 
standards at the ionic strengths given, the contribution of 
comPonents except NaCl towards ionic strength (following 
adJustment of the solution to PH 7.4 with NaOH> was 
calculated using the classical formula 
u = 1/2 L CiZi 2 
where: 
u = ionic strength 
Ci = molar concentration of the ion' i 
Zi = the charge associated with ion' i. 
An aPProPriate amount of NaCl was then added to bring the 
solution to the desired ionic strength. All standards 
contained 5.0 mM KC! and 0.55 mM MgC1 2 along with var~ing 
amounts of CaC1 2 and NaCl. 
B> Individual Ion Activities- A variet~ of conventions 
are available for estimating the activit~ coefficients of 
individual ions at various ionic strengths. The data of 
Kielland was used b~ aPPl~ing Pol~nomial regression anal~sis 
on the logarithm of the ionic strength as the independent 
variable versus the activit~ coefficient. Second degree 
Pol~nomials fit the data well <P < .001) with ma:<im•Jm 
residuals of less than 5 Percent. A comparison of the 
values obtained b~ various conventions along with those 
PAGE 7 
estimated by the resression analysis <PR-K> are Presented in 
table 2 alons wi +h the resression parameters. 
In this rePort, molar concentrations will be 
represented b~ brackets and activit~ by Parentheses. 
C> Serum Ionized Calcium- These values were obtained 
by use of the eauation [Cat+J = antilog ((intercept - mV 
reading)/ slope). The mV readings of two calcium standards 
C0.5 and 5.0 mM> were taken in duplicate both before and 
after a series of samples were run. The slope was 
calculated bY taking the difference in mV readinss of 
averase values obtained for low calcium and hish calcium 
standards. The averase mV reading of the 1.0 mM calcium 
standards bracketing the sample was used in the eauation to 
calculate the intercept for that sample. Earl~ studies 
conducted with this system resulted in the observation that 
stead~ baseline drifts occured over the ranse of 
concentrations of standards employed. In addition, a 
parox~smal shift in the mV reading for a samPle or standard 
w~s observed. Errors associated with both t~Pes of shifts 
are attenuated by this calculation Procedure. 
Selecii~ii~ Raiics The eauimolar concentration <0.1 M), 
separate solution method as described by Srinivasan and 
Rechnitz (25) was used to determine selectivity ratios while 
the electrodes were removed from the samPle chamber. 
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Selectivitw ratios are Siven bw: 
( ( 
Eca - Ei )~ ( Kca-i = antilog S ~ 
where: 
K ca-i = selectivitw ratio of the calcium ion 
specific electrode for the interferins ionr i. 
E ca = observed Potential of a 0.1M CaC1 2 solution 
E i = observed Potential of a 0.1M solution of the 
interferins ionr i. 
S = 2.3 RT/2F = Nernstian slope with theoretical 
values of 29.58 at 25°c and 30.77 at 37°c. 
<Ca++> = activitw of calcium in moles/L. 
<i> = activitw of the interferins ion in moles/L. 
Calcium ~lbumioaie ~ioeiics Bovine serum albumin <BSAr 
Sisma Co.> at a concentration of 6s/dl was Prepared in 50 mM 
acetate buffer (PH 4.4), dialwzed at 4°C for 24 hours with 
two fortw-fold volume chanses and subseauentl~ dialwzed in a 
similar manner in 50 mM TRIS/HCl buffer <PH 7.4>. Dialwsis 
at the isoelectric Point of albumin served to reduce 
initiall~ elevated Potentials observed followins the 
Preparation of Proteins in TRIS buffer directlw. The 
elevated Potentials were due Primarilw to low levels of 
calcium liberated from the BSA; a findins confirmed 
oualitativel~ bw atomic absorPtion SPectroscoP~. FollowinS 
dial~sis the resultant concentration of BSA was 4 s/dlr and 
to 10ml of this solutionr 5, 10, and 20ul aliauots of 
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CaC1 2 <200mM> were added incrementallw and ionized calcium 
determined+ TRIS was selected as an approPriate buffer 
since the data of Mohan and Bates <14) showed calcium does 
not bind to TRIS over the ranse 0.01 to 0.1 M. 
Statistical ~oal~sis The method of least sGuares was used 
to calculate resression Parameters of second and first 
Polwnomials. Tests of sisnif icance between 
resression coefficients were Performed usins the t-statistic 
as described bw Steel and Torrie <26). Where aPProPriate, 
the indePendent sample or repeated measures t-statistic was 
aPPlied. 
Se~um Sameles Human blood samples were collected using 10 
or 15 1111 •vacutainers• <red top, no additive; 
Becton-Dickson; Rutherford, N.J.) via the median cubital 
vein. The blood was allowed to clot at room temperature for 
20 minutes' centrifuged at 1000 x g x 10' and serum removed 
anaerobicallw using a disposable swrinse and needle. The 
serum <1 ml) was transferred to a 2+0 ml Vacutainer with the 
aid of a swrinse and either stored on ice until readw for 
assaw or frozen at -20°c. 
Rat blood was collected using a disposable 3 ml s~rinse 
following light ether anesthetization b~ Puncturing the 
inferior vena cava. The blood was transferred anaerobicall~ 
into a 3 ml Vacutainer and Processed as described for human 
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serum. 
Iesi of ~oaerobic Coodiiioos Individual serum samples were 
collected anaerobicall~ in 1 ml tuberculin s~rinses and Put 
on ice. Prior to measuring ionized calcium' PH measurements 
were made and the remaining sample was Processed through the 
sample chamber and the PH was again measured upon its 
removal. 
Siaiic I~ee Elecirode ~ersus tbe Orioo SS=20 Sera of 10 
normal volunteers (ages 22 to 42 for males and 21 to 32 for 
females) were run in triPlicate on the Orion SS-20 accordins 
to the manufacturer's instructions and also on the apparatus 
described in this report. The remaining serum was Pooled 
anaerobicall~ and six 1 ml samples withdrawn and Placed into 
2 ml Vacutainers for each of the following treatment groups. 
A small volume (up to 20 ul> of CaC1 2 or EDTA was added to 
each Vacutainer. 
~eelicaiioo Male COBS/CD rats <Charles River Co.; 
Wilmington' Mass.> weighing 350±50 grams were group housed 
and fed food and water ad libitum. Ten and thirt~ minutes 
Prior to sacrifice' rats were inJected subcutaneous!~ 
<lml/kg) with saline' CaC1 2 or EDTA. Total serum calcium 
was measured using the 0-cresoPhthalein comPlexone reaction 
<Sigma Co.>. 
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RESULTS 
Eleci~ode ~eseoose Iime The resultant effects of 
incorporating the electrodes into the chamber on electrode 
resPonse time were evaluated using standards and samples at 
both 25 and 37°c. The results illustrated in fisure 4 were 
reported as deviations (in mV> from the 5 minute readins 
since the readings were shown to be stable from 5 to 30 
minutes. Shorter response times were obtained with 
measurements determined at 25°c. Although the data converse 
on an eGuilibrium value at 5 minutes, it should be made 
clear that the mV readings for samples and standards were 
different at the two temperatures studied. 
Based upon the data shown in figure some 
Guantitative differences associated with ionized calcium 
measured at the two temperatures would be expected. While 
mV measurements made at 37°C following a delaw of 4 minutes 
deviate from the eGuilibrium value bw aPProximatelw 0.11 and 
0.17 mV for samPles and standards, resPectivelw, thew do not 
significantlw differ from each other <P>0.05). Since the 
standard deviations associated with measurement at this time 
Point are smallr the 4 minute reading would be expected to 
Sive results virtuallw identical to the eGuilibrium value. 
The 2s 0 c measurements made at 1 minute howeverr while thew 
averase close to the eGuilibrium value, are themselves 
significantlw different from each other <P <0.05) with the 
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standards readins aPProximatel~ 0.25 mV hisher than the 
samples. To correct for this effect, the difference in mV 
<0.25) is either added to the observed Potential for the 
sample' or subtracted from the averase observed Potential 
for the standards bracketins the sample. This value is 
aPProximatel~ 0.02 mM calcium. 
Fisure 5 illustrates the effect of temperature. The 
difference between the value obtained at 25°C corrected for 
eouilibrium effects and those at 37°c is 0.04 mM ca, or 
aPProximatel~ 4%, a value consistent with those Previouslw 
observed in the literature (2, 10). 
ecti~ii~L Selecii~ii~ aod Mola~ Ccoceoi~aiioos Ion specific 
electrodes of the twPe emPlowed here have been shown to 
respond in accordance with the extended Nicolskw- Eisenman 
eouation (7). 
2/Z· E= e0 +S log ((Ca++)+ Kca-i <i> '> 
where: 
E = observed Potential 
E 0 = sum of Potentials orisinatins from the 
reference electrode' the fillins solution of the 
ion-specific electrode and the liauid Junction 
Potential. 
Remainins terms as Previousl~ defined. 
Conformance to this eauation was used as a criterion for 
assessins the Performance characteristics of the electrode 
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swstem. 
Table 3 depicts the results of selectivitw ratios 
evaluated for ions of Primarilw Phwsiolosic interest for 
each of two lot numbers of calcium sensins modules. The 
selectivitw ratios obtained exPerimentallwr when compared 
with calculated values Presented in table 4, determine which 
ions sisnificantlw contribute to the observed Potential 
throush a selectivitw effect. 
Table 5 shows the resression Parameters for calcium 
standards C0.5 to 1.7 incremented bw 0.3 mM> prepared at the 
ionic strensths indicated. Resression Parameters reveal 
identical slopes onlw when the activitw and selectivitw 
effects are accounted for in the analwsisr as Predicted bw 
the Nicolskw-Eisenman eauation. 
Calcium:Albumioaie Kioeiics The results of this experiment 
depicted in fisure 6A indicate aPParentlw two saturable 
calcium bindins components associated with BSA. The data, 
analwzed as described bw Moore (16> and illustrated in 
fisure 6Br reflects the two saturable sitesr each of which 
maw be fitted accuratelw usins linear resression analwsis. 
Replication of the experiment resulted in essentiallw 
identical findinss concernins the number of saturable 
components. The averase results of three independent 
experiments save calculated dissociation constants (PK> for 
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the high and low concentration <subscriPted 
respectively H + L> and number of binding sites <n> of <mean 
± s.ri.) PKH = 1.9±.4, PKL = 2.9±.1, nH = 12.7±2.2 and n L = 
1.9±.4. More importantly, after the electrodes had been 
exposed to solutions containing Proteins, the change in the 
observed Potential of the aGueous standards from the 
beginnins to the end of the run was consistent with 
within-day variation characteristically observed when the 
electrodes had been used only with Pure aGueous standards, 
sussesting that the electrodes can withstand the Presence of 
Proteins. 
~~ Effects A> Protein-Free Solution- Ionized calcium was 
determined at various levels of PH usins 1.0 mM calcium 
Prepared in 50 mM TRIS at PH 6.7, 7.4 and 7.9 with NaCl 
adJusted to a resultant ionic strength of 0.16 moles/L. The 
relationship between ionized calcium and PH was found to be 
~[Cat+J mM = -0.087 ~PH, a val•Je virt1JallY identical to 
the relationship offered by Grima and Brand (9). These data 
suggest small but significant errors are associated with PH 
changes over the physiological range. 
B> Protein Solutions- Studies sind lar to those 
reported in the calcium-albuminate kinetics section were 
Performed at PH 5.5 where it was observed that 0.43 mM Ca 
was bound to albumin at 2.5 mM total calcium. ComParins the 
value obtained at PH 7.4 of 1.3 mM bound, described in the 
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Preceding section, results in the PH dependent relationshiP 
Arca++J mM = -0.46 APH and adJusting for the Protein 
concentration of 4 g/dl in this studw compared with 4.73 
g/dl used bw Moore, the correlation coefficient becomes 
-0.39 which is reasonablw close to the value of -0.42 
reported bw Moore <16>. The range of values varies from 
-0.49 to -0.35 <6, 1a, 24>. It maw be concluded that the 
electrode swstem is responsive to the change in free calcium 
associated with varwing PH in Protein solutions. 
C> Test of Anaerobic Conditions- The results <table 6) 
susgest that a sisnificant increase in PH maw result, but 
the masnitude of the change, i.e. < Arca++J = -0.39 >: APH = 
-0.39 x (.047) = -.018> is less than the error associated 
with the Precision of the measurement. 
Elecirode £erformaoce During a 23 daw Period both serum 
samples and standards were measured and the daw to daw and 
within daw variations of the standards were calculated with 
the results Presented in table 7. The data illustrates 
several imPortant considerations. Electrode stabilitw is 
fairlw Sood as reflected bw a maximum coefficient of 
variation of 1.5% associated with the 0.5 mM standard. 
Within daw variation is appreciable and warrants the 
calculation protocol described in the methods section' 
wherebw each sample is bracketed bw the standards. The 
sloPe does not change aPPreciablw from the beginning to the 
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end of the run, Justifwing the use of the average mV slope 
determined for the daw in the calculation of ionized 
calcium. The relative mV readings for a siven sensing 
module maw differ significantlw from anw other module as 
Previouslw shown in table 3. In addition, the data used for 
the Preparation of tables 5 and 7 utilized two different 
sensing modules. The average mV reading for standards given 
in table 7 maw be compared with calculated mV values for the 
same calibration standards obtained using the regression 
Parameters of table 5, u = .16, [Cat+J, 25°c. These values 
are 30.51, 38.67 and 57.63 mV for 0.5, 1.0 and 5.0 mH 
calcium resPectivelw. 
Siaiic=I~ee Electrode ~ersus ibe Orioo SS:20 The means of 
triPlicate serum samPle determinations run on the SS-20 and 
the static-twPe electrode swstem are compared in figure 7. 
The correlation was considered to be excellent with over 97% 
of the variation accounted for bw regression. 
Samele Storage Human serum samples frozen at -20°c for 
varwing Periods of time were assawed to determine the 
effects of storage. Figure 8 illustrates a significant 
increase in calcium following storage, a result at variance 
with most reported studies. This result suggests that the 
effect of storage conditions deserves more thorough 
characterization. Under the Siven conditions, unless 
measurements are made immediatelw' the duration of freezing 
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should be identical from one sample to the next and should 
not exceed two weeks. 
~eelicaiioo Results The effects upon the observed serum 
total and ionized calcium, as a result of the administration 
of CaC1 2 or EDTA, are Presented in table 8. Rats 
administered EDTA showed a Profound decrease in both total 
and ionized serum calcium whereas a sisnificant increase in 
serum ionized calcium was observed for CaC12 treated aminals 
despite a small but insisnificant increase in their total 
serum calcium. The results confirm the in-vitro effects of 
CaC1 2 and EDTA and SUPPort the view that the s~stem 
described here can easil~ resolve 10% chanses in serum 
ionized calcium. 
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DISCUSSION 
Several criteria must be met before calcium 
ion-specific electrodes maw be used to determine serum 
ionized calcium. These criteria are associated with either 
the Phwsical conditions under which measurements are made, 
the Performance of the electrode or the composition of the 
sample. Since the static-twPe electrodes have not been 
recommended for the determination of ionized calcium in 
serum, this report focuses on the various criteria and 
demonstrates how each have been satisfied in terms of the 
experimental results. 
Concerning the Phwsical conditions surrounding the 
measurement itself, the determination should be made 
anaerobicallw on a sample of fixed volume at constant 
temperature. An~ instrument desisned to measure serum 
ionized calcium should be capable of retaining the original 
of the sample following the measurement, since 
alterations in PH can substantiallw alter the measurement. 
The ISE samPling chamber Provides for auasi-anaerobic sample 
Processing, as shown bw the PH data Provided. 
Arnold et al. (2) demonstrated the dePendence of the 
measurement upon sample volume, which is fixed in the 
aPPParatus described here at 0.6 ml. This value is not 
considerablw different from the volume of sample reauired 
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for use of the ss-20. 
The ideal conditions for determinins serum ionized 
calcium are those which most closel~ reflect Ph~siolosic 
conditions. A variet~ of temperatures have been used 
includins 20°c <2>, 2s 0 c <12), 26°c (19), 27°c <22> and 37°c 
18). Althoush we have demonstrated the 
caPabilit~ of oPeratins the instrument at 37°c, 25°C was 
selected since the shorter eauilibration time allows for a 
considerabl~ sreater number of samples to be Processed Per 
da~. The difference of 4% lower values at the hisher 
temperature does not Justif~ its use especial!~ in view of 
the slishtl~ sreater desree of variabilit~ associated with 
measurements made at the elevated temperature. 
The static-t~Pe electrode is normall~ Placed into a 
sample which is continuous!~ stirred. The electrode chamber 
does not allow for continuous stirrins and thereb~ ma~ 
result in a Prolonsation of the time reauired to achieve 
eauilibrium at the sample electrode interface. In addition' 
since the sample compartment volume is fixed, the flow rate 
of the reference electrode fillins solution ma~ be impeded 
and as a result contribute to unstable readinss. Althoush 
response times were Prolonsed compared with the data 
Provided b~ the manufacturer' the readinss were stable. 
Earl~ models of the static-t~Pe electrode were 
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rePortedlw Poisoned bw Proteins renderins the electrode 
unsuitable for use in the determination of serum ionized 
calcium (16). 
Prolonsation of 
Later 
their 
models were shown to exhibit a 
response times and PromPted the 
Practice of incorPoratins triethanolamine and trwPsin into 
the standards in an attempt to remove the residual Proteins 
from the membrane. The use of these orsanics has become a 
subJect of controversw (20>. The studw of the kinetics of 
calcium bindins to albumin was viewed as a viable 
experimental approach to assess the value of the static-twPe 
electrode considerins the intended application. Temperature 
comparisons adJusted for response times and calcium 
albuminate kinetics reflect the refractiveness of the 
membrane to anw Potential Poisonins effects of the Proteins. 
Response times are not altered aPPreciabl~ bw the Presence 
of Proteins. Ca-albuminate studies did not result in an 
extraordinarw effect in the mV readinss when the observed 
Potential of standards taken Prior to sample assaw were 
compared with values followins exposure of the membrane to 
Proteins. Pedersen <17) Provided evidence to sussest that 
12 of the 16 histidine residues serve as the bindins sites 
for calcium to human albumin' a number not far from the 
exPerimentallw determined value reported here for the hish 
concentration ranse <2 5 mM> of total calcium. The 
arithmetic means of the PK's at 2.4 and n's at 7.3 compare 
reasonablw well with those obtained b~ Moore <16), PK= 2.2 
and n = e.4, who reported onl~ one saturable component. 
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An electrode should be capable of withstanding changes 
in PH over the range of Ph~siological interest. The 
electrode emPlo~ed here is not entirel~ independent of PH 
effects but the magnitude of the change in Potential as a 
function of PH is not sufficientl~ large to warrant further 
consideration. The PH dependence data of calcium albuminate 
kinetics is in agreement with values reported by others. 
ISEs measure ion activity and not the molar 
concentration of the ion itself. Their use in the 
measurement of serum ionized calcium is Justified by the 
view that standards Prepared at the same ionic strength as 
samples results in identical activity coefficients for the 
ions of interest. This is not entirel~ true, however, since 
it has been shown that the activit~ coefficient of sodium 
varies at constant ionic strength and varYing mole fraction 
in a solution containing sodium and calcium. Similar!~, the 
activity coefficient of calcium varies in Proportion to its 
mole fraction at constant ionic strength <15). These 
effects have generall~ been ignored and to consider them 
here would reauire considerable deviations from the 
traditional use of the calcium !SE. However, it is 
noteworthy in terms of obtaining an aPPreciation for the 
limitations of this method. 
The ionic strength of standards is usuall~ near that of 
serum which is considered to be aPProximatelY 0.16 moles/L 
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with the PrinicPal contributors beins Na and Cl. The 
composition of standards emPlowed for the determination of 
serum ionized calcium varies from a sodium concentration of 
140 to 160 mM (2, 23>. Some investisators emPlow 
Phwsiological concentrations of K and Mg while others 
include orsanics <TRIS or trwPsin and triethanolamine>. 
The effe~ts of chanses in ionic strensth on the 
observed Potential is demonstrated in table 9. These 
calculations are in close agreement with those of Moore 
( 16) • Assuming the electrode is specific for calciumr i.e. 
selectivitw ratios for Potentiallw interfering ions are 
small, the masnitude of error both in mV and apparent 
ionized calcium is shown for a 10 and a 70 mM sodium chanse. 
The imPlications of the values reported in this table are 
<1> assumins ionized calcium concentrations are closely 
regulatedr the values reflect the degree of variability that 
would be expected bw a comparison of studies in the 
literature 
strength; 
which emPlow standards of differins ionic 
<2> assumins sodium and not calcium 
concentrations of serum samples vary considerably, the 
values reflect the errors associated with an apparent chanse 
in the concentration of ionized calcium. Similarlw' the 
errors are calculated for the combined effect of changing 
ionic strensth on the activitw of the ion Plus the 
selectivity component. Selectivitw effects tend to offset 
the reduction in apparent ionized calcium brousht about bw 
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changing ionic strengths. The obJective of the measurement 
is to determine the molar concentration of ionized calcium 
and not the activit~, thereforer a significant selectivit~ 
component actuall~ serves to minimize the error brought 
about b~ changes in the concentration<s> of interferins 
electrol~te<s>. 
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SUMMARY 
The method described here may be used for the 
determination of serum ionized calcium. The PhYsical 
conditions of the measurement, including samPle volume <0.6 
ml) and temperature (25 or 37°c>, are fixed. Stasis of the 
sample may contribute to a Prolonged but not Prohibitive 
response time. Other than the Prolonged response time' the 
Performance characteristics of the electrodes were not 
altered bY incorporating them into the electrode chamber. 
ExemPlifYing the utility of this method were the results of 
Protein binding studies' in-vitro and ex-vivo CaC1 2 and EDTA 
administration and a comParison with the Orion SS-20. In 
consideration of the data Presented, the cost and simPlicitY 
of construction' the method described should serve to make 
the determination of serum ionized calcium accessible to a 
greater number of investigators and encourage research in 
Pharmacological and PhYsiological Processes thought to be 
mediated by serum ionized calcium. 
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Table 1. Critical Dimensions and DescriPtions of Plastic 
<Plexislas<R>> Serum SamPlins Chamber 
Qt!:I. Item Size 
UPPER ASSEMBLY 
2 sides 2 • >:2 + 5 I}•! t 25 I 
1 top 2 1 }·!2 + 5 I}•!• 25 I 
2 front & 2 I }•!2 t 5 I)! t 25 I 
back 
1 bottom 2. }·!2. 5. >!. 5. 
LOWER ASSEMBLY 
2 sides 2. }·!1. }·!. 25. 
2 front & 2•x1•x.2s• 
2 
back 
top & 
bottom 
Description 
with 11a· Hlf'T male adapter 
fitted in one corner 
with two s;a· holes drilled 
with two 5;9• holes drilled 
with 110• MIPT male adaPter 
fitted in one corner 
f'AGE 30 
PAGE 31 
Table 2. Comparison of Various Conventions Used for the Determination of Sin9le Ion 
Activity Coefficients at 25°C 
Ion 
Ca 
Na 
Ionic Stren!!lth 
.001 
.01 
.09 
.10 
.125 
.16 
.001 
.01 
.09 
.10 
.125 
.16 
a Bates & Alfenaar (3) 
b. Grima & Brand (9) 
c Brand & Scott (4) 
d Ammann et al~ <1> 
PH 8 
.8721 
.6677 
.3895 
.9661 
.9036 
.7798 
Maclnnes8 
.3959 
.8709 
Extendedb 
Debye-Huckel 
.8697 
.6758 
.4129 
.3798 
.3761 
.3501 
.9651 
.9022 
.7803 
.7731 
.7575 
.7400 
Daviesc 
.8655 
.6525 
.3185 
.3025 
.2696 
.2346 
.9640 
.8927 
.7170 
.7042 
.6754 
.6406 
Batesd 
.8684 
.6689 
.3983 
.3864 
.3623 
.3375 
.9651 
.9025 
.7862 
.7797 
.7660 
.7510 
x±2S.D. 
.8689±.0055 
.6662±.0196 
.3766±.1016 
.3686±.0885 
.3360±.1158 
.3074±.1267 
.9650±.0018 
.9003±.0101 
.7612±.0767 
.7815±.1185 
.7330±.1001 
.7105±.1216 
e Polynomial Re9ression aPPlied to the transformed data of 
Kielland <11) 
PR-Ke 
.8688 
.6773 
.4123 
.3976 
.3658 
.3296 
.9663 
.9018 
.7828 
.7757 
.7602 
.7424 
where: 
< lo9 u>2 activity coefficient = bO + bi 109 IJ + b2 
Ca .0296 - .4121 - .0441 
Na .5880 - .2185 -.0308 
M9 .1263 - .3512 - .0346 
K .5281 - .2602 -.0380 
Table 3. Selectivity Ratios Determined for Ions of Physiologic Interest 
i [ i Ja u Gib E<LS-1>c Kca-i<LS-1>d E<L0-1> Kca-i<L0-1> 
Ca 
Na 
K 
Ms 
0. 1 0. 3 • 2330 
0. 1 0. 1 • 7757 
0 .1 0. 1 • 7503 
0. 1 0. 3 • 3007 
91. 71 
o.51 
-0.32 
-1.84 
2. 71;.:10 
2.7 >{10 
4.5 N10 
a. [iJ = molar concentration of ionr i. 
b. Gi = activity coefficient of ionr i. 
90.3 
-11.3 
-8.2 
-7.3 
1.13;-:10 
1.55;·{10 
3.1 ;-:10 
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c. E = observed Potential using the sensing module indicated in Parentheses. 
d. Kca-i = selectivity ratio associated with calcium ion-specific electrode 
sensing module for ion, i. 
TABLE 4. Errors Associated with Calculated8 Values of 
Selectivit~ Ratios 
I 
Na 
K 
Mg 
u=.09 
7. 32;·:10 
2. 38;·:10 
7.88;·: 10 
Kca-i 
u=.16 
2. 09;·:10 
2+19;.:10 
7. 88;.:10 
a. Yielding errors in apparent calcium in 
e;.:cess of 0.1 mM using the Nicolsk~-Eisenman 
ea1Jation. 
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TABLE 5. Linear Resression Parameters for Standards at Varins Ionic Stren~ths 
ComParins Molar Concentration' Molar Activity and Molar Activity + Selectivity 
Variable8 
ECa++J 
<Ca++> 
<Cat+ + 
Kca-na Na2> 
CCat+J 
<Ca++ + 
Kca-na Na2) 
u <25°C> 
.09 
.125 
.16 
.09 
.125 
.16 
.09 
.125 
• 16 
u <37°C> 
.09 
.16 
.09 
.16 
* arithmetric mean 
Slope 
mV 
29.07 
28.08 
27.12 
29.075 
28.08 
27.098 
30 .102 
30.023 
30.478 
30.201* 
35.025 
29.967 
36.26 
34.71 
Intercept 
mV 
126.08 
123.227 
120.034 
137.903 
135.498 
133.030 
140.939 
141.267 
143.237 
141.814* 
151. 858 
136.144 
168.990 
165.37 
r2 
.9964 
.9959 
.9989 
.9964 
.9959 
.9988 
.9964 
.9960 
.9990 
.9911 
.9811 
• 9911 
.9805 
S .E. of 
estimate 
rr1V 
.1469 
.1582 
.0736 
.1481 
.1530 
.0794 
.1490 
.1504 
.0711 
.2816 
.3234 
.2813 
.3674 
a. brackets represent molar concentration of the ion' Parentheses 
represent activity of the ion in moles/L. 
b. the null hypothesis: slope at one ionic stren~th is eaual to that 
at another ionic stren~th. 
] 
] 
] 
] 
] 
] 
] 
] 
HO: Su1 = Su2 b 
N.S. 
N.S. 
N.S. 
P<.05 
N.S. 
N.S • 
P<.001 
N.S • 
] P<.001 
J F'<. 001 
] N.S. 
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Table 6. Effect of Sample F'rocessin~ on PH 
serum PH C:Ca++J serurrr PH 
before nrM after 
7.369 1.030 7.446 
7.362 1.112 7.415 
7.362 1.127 7.422 
I 
7.365 1.127 7.399 
7.385 1.135 7.398 
7.372 1.135 7.415 
mean 7.369 1.011 7.416 
±.009 ±.041 ±.018 
c.v. .24/. 
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Table 7. Electrode Performance Characteristics 
Variation Cmean±S.D.> n = 23 
Ca standards 
mM 
o.5 
1.0 
5.0 
slope 
Within I•a~ 
mV 
1.40±0.65 
1.14±0.59 
1.14±0.50 
0.45±0.27 
Between I•a~s 
Rel. mV 
35.61±1.41 
44.09±1.44 
63.80±1.21 
28.19±0.94 
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Table 8. The Effect of Subcutaneous Administration of CaCl2 . or 
EDTA upon Total and Ionized Serum Calcium in Rats 
Percent of Control ± S.D. 
Time<min> Treatment8 n [Ca++Jb p [CaJC 
Controld 8 100.0±2.2 100.0±4.6 
p 
10 EDTA-100 8 78.5±3.5 
5 71.5±9.4 
< .001 81.5±2.2 < .001 
< .001 78.6±6.9 < .001 
30 CaCl -250 4 111.4±11.5 <.020 102.1±5.2 N.S. 
350 6 108.1±3.6 < .001 104.2±4.1 N.S. 
500 4 113.6±8.4 < .010 111.6±7.5 N.S. 
a. The numbers shown are doses of CaC1 2 and EDTA in mg/kg. 
b. Serum ionized calcium. 
c. Total serum calcium. 
d. Saline inJected controls for 10 and 30 minutes were not 
significantl~ different from each other. The Pooled control 
values were CCa++J = 1.149±.025, CCaJ = 2.418±.112 mM. 
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Table 9. Estimates of the Hasnitude of Error Associated with 
Either Activit~ (a) Effect Alone or Combined Activit~ 
Plus Selectivit~ Effects <a+k> 
Effect Condition 
"(a+k> 135-145mM Na 
(a) 135-145mM Na 
<a+k> 90-160mM Na 
(a) 90-160mM Na 
a AnrV 
-0.220 
-0.390 
-1.90 
-2.94 
-0.019 
-0.033 
-0.149 
-0.221 
a. for each condition E = E 0 + S los<Ca++ + Kca-na Na+ 2 > 
is calculated and the difference tabulated as 4mV 
E 0 = 141.814 S = 30.201 means of values taken from 
table 5, 25°c 
b. for each effect [Ca++J = anti-los<<E-E 0 +AmV>IS>> and 
the deviation from 1.0mM tabulated asACCa++J 
E 0 = 120.034 S = 27.12 values taken from table 5. 
E for 1.0mM [Ca++J calculated to be 38.674 
ElGU~E 1 
EIGUEE 2 
TITLE: Pictorial representation of the 
calcium ion-specific electrode chamber 
TITLE: Pictorial representation of the bottom 
Plate of the electrode chamber 
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ElGUaE 3 PhotosraPh of the experimental apparatus 
assembled for the determination of 
serum ionized calcium 
EIGUaE ~ 
LEGE~D 
ElGUaE 5 
LEGE~D 
TITLE: Response times of the electrode s~stem 
incorporated into the electrode chamber 
Each point illustrated is the mean of 6-8 
determinations with the standard deviation dePicted. 
TITLE: The effect of samPle Processins 
temperature on serum ionized calcium. 
Each Point illustrated is the mean of 10 individual 
determinations with the standard deviation dePicted. 
EIGU~E 6 
LEGE~D 
EIGU~E Z 
LEGE~D 
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TITLE: Calcium binding to bovine serum albumin 
A> Each Point reflects the calculated result of 
seouential additions of aliouots of a CaC1 2 stock 
solution with readings taken at 2s 0 c, 1 minute 
following each addition. 
B> The data of figure A replotted to give an estimate 
of the Parameters of calcium binding to bovine 
serum albumin. 
TITLE: Correlation between ionized calcium measured 
on the Orion SS-20 with that determined using 
the static-type electrode 
Qpen circles denotes serum samples to which either 
EDTA or CaC1 2 have been added. Closed circles dePict 
values obtained using normal serum samples. Each 
Point illustrated is the me~n of triPlicate 
determinations. 
EIGU~E 8 
TITLE: Effect of the duration of serum sample storage 
at -20°c 
LEGE~D 
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Each value illustrated is the mean of triPlicate 
determinations with the standard deviation dePicted. 
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MECHANISMS OF ANTIDEPRESSANT ACTION: 
UPTAKE BLOCKADE OR SERUM IONIZED CALCIUM 
PAGE 51 
INTRODUCTION 
The most popular view concernins the mechanism of 
tric~clic antidepressant action mediatins the clinical 
response remains eauivocal in view of accumulatins data. 
The biosenic amine h~Pothesis of affective disorders is 
based uPon clinical and experimental findinss and has been 
extensivel~ reviewed <lrl4r40r45). Brieflwr the h~Pothesis 
states that depression maw come about as a result of a 
•functional depletion• of one or more neurotransmitters in 
the brain. Functional depletion means there is too little 
neurotransmitter Present or the neurotransmitter is 
incapable of beins released. Alternativelwr there ma~ be a 
Post-s~naPtic receptor deficit resultins in a loss of 
efficac~ of released amines. Serotonin (44)r dopamine <27> 
and acet~lcholine <21) have all been implicated but 
norePinePhrine has beenr bw farr the most extensivelw 
studied neurotransmitter <39>. 
The neurotransmitters mentionedr with the exception of 
acetwlcholiner are believed to be inactivated within the 
swnaPse Partlw bw a pre-swnaPticr hish-affinitwr transport 
mechanism which serves to conserve the neurotransmitter bw 
accumulatins it back into the nerve endins from which it was 
released (19>. Tricwclic antidePressants have been reported 
to be effective in blocking the neurotransmitter re-uptake 
mechanism resultins in an accumulation of these amines 
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within the swnapse. Uptake blockade has been viewed as a 
mechanism wherebw tricwclics maw reverse the functional 
depletion of neurotransmitters and conseauentlw elicit a 
therapeutic response. 
One of the Problems associated with the uptake blockade 
mechanism of therapeutic action Proposed for the tricwclic 
antidepressant~ is the aPParent lack of temporal correlation 
between the onset of the therapeutic effect and that of the 
exPerimentallw observable biochemical effect. Tricwclics 
must be administered for two to three weeks before anw 
therapeutic effect becomes evident <32>. Uptake blockade of 
serotonin and norePinePhrine into brain slices or a crude 
Preparation of Pinched-off nerve endinss (swnaPtosomes) maw 
be demonstrated in-vitro (7,35,39) and ex-vivo followins 
acute (36r42) or chronic (2) administration to rats. 
The most serious criticism of the uptake blockade 
mechanism of action of tricwclics has not been thoroushlw 
challensed. Whereas uptake blockade maw be demonstrated 
followins acute or chronic dosins of antidepressants, a 
comparison of the masnitude and duration of this effect has 
not been made. Criticisms have therefor been based upon 
aualitative evidence. Cummulative dosing maw be expected to 
result in effects which are either more Prolonsed and/or 
Sreater in masnitude than that elicited followins acute drus 
administration in which steadw-state blood levels have not 
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wet been achieved. The first hwPothesis addressed in this 
studw is that chronic ProtriPtwline <PRO> administration 
results in a sreater masnitude and/or duration of uptake 
blockade activitw compared with that elicited bw acute 
administration of the drus. Experimental support for this 
hwPothesis would reaffirm uptake blockade as the explanation 
for the biochemical mechanism bw which tricwclics elicit 
their therapeutic effects. 
Several lines of investisation converse to sussest an 
alternative view of antidepressant activitw to that of 
uptake blockade and features a role for calcium ions. 
Calcium metabolism in affective disorders has been studied 
with eauivocal results. Courauilt et al~ (6) reported 
elevations in both serum total and ionized calcium 
correlated with clinical recoverw among depressives treated 
with either a tricwclic antidepressant or a monoamine 
oxidase inhibitor. Frizel and co-workers <13> failed to 
establish sisnificant increases in ionized calcium 
concomitant with PharmacotheraPw but their data reflect a 
trend towards decreases in this response measure durins 
depression and increases following recoverw. Other studies 
of calcium metabolism in depression did not emPlow serum 
ionized calcium as the response measure but rather total 
serum calcium, cerebrosPinal fluid calcium or mineral 
balance methodolosies were utilized. Here too' the results 
are less than clear with some rePortins trends towards 
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increases in calcium following recoverY from depression 
C9-12r17r18r31) and others reporting the reverse effect 
C4r20> or no effect <28>. Clark et al. (5) reviewed the 
evidence for linking affective disorders with 
hwpo-Parathwroidism. 
Thwroid hormone status has been associated with 
affective state as well (15). Stimulation of the 
hYPothalamic-Pituitarw-thwroid a}: is is acutely but 
transiently effective in depression (8). Prange et al. 
<34> reported a reduction in the latency of the therapeutic 
resPonse of tricwclics with concomitant thwroid hormone 
administration. The antidepressant activitw of thwroid 
hormone and its relationship to calcium maw be assumed b~ 
the observation that 47% of hwPerthwroid individuals were 
shown to Possess elevated levels of serum ionized calcium 
( 3) • In additionr there is evidence suggestive of a 
functional relationship between cells of the thwroid gland 
elaborating thwrocalcitonin and those which secrete thwroid 
hormone < 28 >. 
Biochemical observations reflecting the imPortance of 
calcium in neuronal functioning suggest that a calcium 
hYPothesis of antidepressant activitw maw be comPlementarw 
to and therebw extend the biogenic amine hypothesis of 
affective disorders. Ca 1ci1J1T1 is reo•Ji red for the 
depolarization-induced release of neurotransmitters <33,37) 
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and Perhaps the swnthesis of norePinePhrine as well (30>. 
There is some evidence that the sPontaneous release of 
neurotransmitter, usuallw viewed as calcium-independent, maw 
be dependent to some extent on calcium <22>. 
The clinical and biochemical observations Presented 
aPPear to Justifw the formulation of a calcium hwPothesis of 
antidepressant activitw. This report concerns the tests of 
three such hwPotheses. The first is that chronic but not 
acute administration of the tricwclic antidepressant, 
ProtriPtwline <PRO), results in an increase in serum ionized 
calcium. The second is that the thwroid hormone, 
triiodothwronine, results in an acute but transient 
elevation of serum ionized calcium. Lastlw, combined 
thwroid hormone and tricwclic antidepressant administration 
results in an acute and sustained increase in serum ionized 
calcium. Evidence suPPortins anw or all of these hwPotheses 
would sussest that calcium maw Pla~ an important role in 
mediatins the observed clinical response. 
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MATERIALS AND METHODS 
~ssa~s Serum sodium and Potassium determinations were 
performed bw flame Photometrw <IL model 143-02>. Glucose 
and blood urea nitrosen <BUN> were assawed with the 
Ministat-S Chemistrw Analwzer <Biokinetix Corp., Mass.). 
Creatinine was measured bw the Jaffe rate method usins a 
Beckman Creatinine Analwzer A Beckman 
Chloride/C02 Analwzer was used for their determinations. 
Inorsanic PhosPhater creatine PhosPhokinase <CPK>r alkaline 
PhosPhatase and total serum calcium were all measured 
colorimetricallw usins kits Provided bw the Sisma Co. <St. 
Louisr Mo.>. 
IL model 
Serum PH, PC0 2 and P02 were analwzed usins the 
413 Blood Gas Analwzer. HwdroxwProline was 
determined bw the method of Kivirikko et al£ (23>. 
Masnesium was determined bw the Titan Yellow colorimetric 
method <43). Protein was assawed usins the method of Lowrw 
and co-workers <26>. Serum ionized calcium was measured 
Potentiometricallw bw the method described in the Precedins 
manuscript. Serum conductivitw was determined usins a 
Radiometer model CD3m conductivitw meter and the data 
expressed as the molar eauivalent of KCl standards. 
Statistical Metbods One waw analwsis of variance was 
emPlo~ed with subseauent Newman-Kuels multiple comParisons 
aPPlied as described bw Winer (46). 
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3~=~o~eeioeeb~ioe Ueiake A modification of the method 
of Sn~der and Co~le (41) was used to determine 
3 H-norePinePhrine uptake. Rats were sacrificed between the 
hours of 11:00 A.H. and 12:30 P.H. to minimize the 
contribution due to diurnal variation associated with 
Animals were lightl~ norePinePhrine uptake (25). 
anesthetized with ether (2.5 minutes> and decapitated 
following the withdrawal of 3 ml of blood via s~ringe b~ 
Puncturing the inferior vena cava. The brains were removed 
from the animals and the h~Pothalami dissected out as 
described b~ Glowinski and Iversen (16). The h~Pothalami 
were Placed into ice-cold 0.32M sucrose until all 
dissections were completed. 
After weighing the tissue, the volume of sucrose was 
adJusted to result in a 10% w/v concentration of tissue. 
The tissue was homogenized in a teflon-glass tissue 
homogenizer with a clearance of 0.03 cm <Arthur H. Thomas 
Co.; Phila., Pa.> usins 10 UP and down strokes at about 
1,000 rPm. The supernatant fraction of a 1,000 x s x 10 
min. centrifugation carried out at 4°C in a Sorvall RC-2B 
centrifuse was used as the crude s~naPtosomal homosenate 
<CSH>. 
The incubation medium was similar to that reported b~ 
Sn~der and Co~le <41> and modified b~ deletins the calcium 
since this ion is not reauired for uptake and ma~ in fact 
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contribute to a reduction in apparent uptake (44, Personal 
observation>. The incubation medium contained (mH>: NaCl 
<118.5), KCl (4.8), KH2PD4<1.2). MsS04(1.2)P NaHC03<24.8), 
disodium eth~lene diamine tetra-acetic acid <0.13), the 
monoamine oxidase inhibitor, nialamide, <0.01) and 
3H-norePinePhrine <0.0001; 2uCi/ml> and was ox~senated for 
20 min. Prior to use with o2 :co2 <95:5> while the buffer was 
kePt cold. Reasents were obtained from Sisma Co., the 
isotope from New Ensland Nuclear <Hass.> and the nialamide 
was donated b~ Pfizer Pharmaceutical Co. <Groton, Conn>. 
Six aliGuots <0.2 ml> of the CSH were eGuall~ divided 
amens o0 c and 37°c incubation conditions usins slass tubes 
<10 mm x 75 mm> which contained o.a ml of incubation medium. 
The resultant Protein concentration was between 1.0 and 1.5 
ms/ml with bovine serum albumin used as the standard. 
Followins a ten minute incubation the reaction was stoPPed 
b~ submersins the 37°c tubes into an ice-bath. All tubes 
were then centrifused at 1,000 x s x 60 min. The 
supernatant was aspirated and 1.0 ml of absolute ethanol was 
added to the Pellet, dispersed b~ vortexins and transferred 
into a scintillation vial. All tubes were rinsed with an 
additional ml of ethanol and the rinse transferred into 
their respective scintillation vials to which was added 10 
ml of toluene Phosphor (5.5 s/l 2,5-diPhen~l oxazole and 125 
ms/l B-bis-<2-Phen~loxazole>-benzene in toluene>. 
Scintillation reasents were obtained from New Ensland 
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Nuclear. 
Uptake was calculated b~ subtractins the mean value of 
the 0°C incubations from those obtained at 37°C. The 
radioactivit~ was measured usins a Packard Tri-Carb model 
3335 liauid scintillation spectrometer. Uptake was 
expressed as ns norePinePhrine/ms Protein/10 min. 
Bcoe Calcium The risht femur was removed from the 
animal and connective tissue dissected free usins a scalPel 
and forceps. The femur was dissolved in 10 of 
concentrated nitric acid and the acid was boiled off. The 
residue was reconstituted with 100 ml of distilled and 
deionized water and calcium determined colorimetricall~. 
~oimals=E~oi~i~i~lioe Stud~ Male COBS/CD rats <Charles 
River Co.; Wilminston, Mass.> weishins 250-275 srams at the 
time of arrival were srouP housed (5/caSe), fed food and 
water ad libitum and left to acclimate for 1 week Prior to 
initiatins the experiment. Each animal received 18 dail~ 
inJections ( 1 ml/ks, with controls receivins 
Ph~siolosical saline' the acute srouP siven 17 da~s of 
saline and on the last da~ 1 dose of PRO <10 ms/ks>. The 
subchronic SrouP received 12 da~s of saline inJections and 
PRO for the last 6 da~s. The chronic srouP received 18 da~s 
of PRO. 
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Five rats from each treatment srouP were sacrificed 
each da~ in random order. The h~Pothalami of rats from a 
Siven treatment srouP were Pooled to result in N=1 for the 
da~. Each week a siven time Point followins the last 
inJection was under stud~ to result in N=5 for each 
treatment condition and time Point. 
aoimals=Cbrooic ~roiriei~lioe aod Iri=iodoib~rooioe 
admioisiraiioo Animals were srouP housed (3/case> and 
treated for 14 consecutive da~s with either saline or PRO (5 
mS/kS) in combination with var~ins doses of 
tri-iodoth~ronine (1, 10 or 100 us/ks>. Three hours 
followins the last inJection animals were anesthetized with 
ether and blood collected via s~ringe from the inferior vena 
cava. 
Hisb Dose ~roiriei~lioe = Balaoce Siud~ Rats were 
individuall~ housed in metabolic cages with food and water 
consumption maniPulated in the weisht adJusted control CC20) 
group to eoual that of the drus treated srouP <P20>. Urine 
assa~s were performed dail~ with blood and bone 
determinations conducted followins the sixth treatment da~. 
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RESULTS 
Eff ecis of Eibe~ ~oesibesia oo 3~=~o~eeioeeb~ioe Uetake 
aod Se~um looized Calcium Since sera must be obtained from 
anesthetized rats, the effect of ether upon norePinePhrine 
uptake and serum ionized calcium was determined. The 
results Presented in f isure 1 demonstrates that ether 
administration did not result in any siSnificant chanse in 
norePinePhrine uptake either in saline inJected controls or 
in animals siven an acute dose of PRO <10 ms/ks>. 
Similarly, the serum ionized calcium of animals Provided 
with an indwellins catheter in the vena cava 1 week Prior to 
samPlins was not different from anesthetized, uncatheterized 
controls (data not shown>. 
e~ot~iet~lioe Stud~ The effect of PRO upon the uptake 
of norepinePhrine (fisure 2> was clearly evident at 2 hours 
after the last inJection with all treatment sroups different 
from controls <P<0.01) but none different from each other. 
Uptake blockade was most Pronounced at 6 hours followins the 
last dose of PRO and returned to control values at 24 hours. 
Amons the various treatment sroups, the values for 
norePinePhrine uptake were not sisnificantlY different from 
each other at anY Siven time Point. In all treatment 
srouPsr the 2 and 6 hour time Points were sisnificantlY 
different from controls <P<0.01). Within the 12 hour time 
Point, the acute sroup did not differ sisnificantlY from 
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controls' whereas the subchronic and chronic srouPs did 
<P<0.01>. 
Serum total and ionized calcium remained unaltered 
throushout the various times and durations of treatment with 
PRO <table 1>. 
!I 3 1 Stud~ Tri-iodothYronine 
administration failed to alter serum total or ionized 
calcium irrespective of the amount and duration of 
administration as well as the time of sacrifice following 
the last inJected dose <table 2>. 
Cb~ooic ~~oi~iei~lioe aod I~i=iodoib~~ooioe A variety 
of response measures known or suspected to be directly or 
indirectly reflective of the status of ionized calcium was 
determined in rats treated with PRO (5 mg/kg) in combination 
with tri-iodothYronine at varying doses. The res•Jl ts' 
Presented in table 3, fail to reveal any PhYsiologicallY 
relevant changes among the response measures. 
There were no significant differences associated with 
serum total or ionized calcium or glucose. Although BUN and 
creatinine values differ from controls, it is the ratio of 
these values which are diagnostic of kidney d~sfunction and 
the ratios do not varY aPPreciablY (37.4, 30.3, 44.9 and 
44.4 for the control and PRO from low to hish dose of 
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thyroid hormone' respectively). Serum electrolytes are 
unaltered as a result of the various treatments. Blood 
Sases are also not sisnificantlY different across treatment 
srouPs. Serum conductivity and proteins remain unchansed as 
well. 
Hisb Dose ~~oi~iei~lioe Althoush total serum calcium, 
inorsanic Phosphate, alkaline Phosphatase' hYdroxYProliner 
femure weisht and femur volume did not differ sisnificantlYr 
there were sisnificant differences in body weisht, serum 
Proteins, bone density and the density of calcium associated 
with bone amons animals treated with PRO <20 ms/ks> for 14 
days <table 4>. 
Hisb Dose e~oi~iei~lioe = Balaoce Stud~ Table 5 
illustrates the results of dailY urine analyses and reflects 
the adeauacy of the attempt to match consumption of food and 
water 
with 
within 
PRO. 
the 
The 
control SrouP with those animals treated 
data sussest, by failure to uncover 
sisnificant differences, that the attemPt to control dietary 
consumption was adeauate. The urine data reflects the 
constancy of homeostasis throushout controls and drus 
treated SrouPs. 
Table 6 depicts the results of blood assays and bone 
studies. All response measures failed to show sisnificant 
differences with the exception of alkaline Phosphatase found 
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to be significant!~ lower in the P20 group. 
Low Dose I~ic~clics PRO <0.5 mg/kg) and imiPramine <5 
mg/kg) administered to rats in an attemPt to reflect doses 
used in humans was studied to cover the 
uncovering an~ biPhasic dose-dePendent 
resPonse measures indicated in table 7. 
possibilit~ 
effects on 
of 
the 
There were no 
significant differences among the various treatments. 
PAGE 65 
DISCUSSION 
Four hwPotheses concerning the mechanisms of action of 
antidepressant substances have been addressed. All utilize 
the same criterion for establishing a Probable causal 
relationship between the biochemical and therapeutic effect, 
namelw, a temporal relationship. Since tricwclics are onl~ 
effective following chronic administration and the converse 
is true for th~roid hormone' alterations in the response 
measures studied · which reflect the temporal considerations 
of the therapeutic agents may offer strong support for each 
hwPothesis in ouestion. 
The results of chronic ProtriPtwline administration 
upon the uptake of 3H-norePinePhrine suggest that multiPle 
dosing maw result in a longer duration of action but fail to 
confirm that the magnitude of the effect is more Pronounced. 
It maw be reasonable to argue that the significantlw more 
Prolonsed duration of action following multiPle dosins 
supports the view that uptake blockade maw be the PrimarY 
effect resulting in the therapeutic response, however, two 
important considerations make this ar~ument less tenable. 
The first is concerned with the data Presented here. 
Although at the 12 hour time Point norePinePhrine uptake 
followins acute administration of ProtriPtwline was not 
significantlw different from control values and both 
multiPle dosins resimes were' the acute value was not found 
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to be sisnificantlw different from the data obtained for 
subchronic and chronic schedules of drus administration. It 
may be offered that although subchronic and chronic drug 
administration resulted in differences from controls during 
this experiment, significance may not necessarily 
reflected following a duPlication of the experiment. 
be 
The 
rational for this interpretation considers that the values 
obtained from all three treatment sroups are a result of 
random sampling since thew did not significantly differ from 
one another. Another random samPling maw result in 
aPProximatelY the same means but for different treatment 
groups. It would have been more convincing if the time 
Point in Guestion was not onlw insignificant when compared 
with controls but significantlw different from the values 
obtained following multiPle dosing. 
Another consideration deals with the actual use of 
tricYclics in the clinical setting. Seldom' if ever' are 
the tricwclics Prescribed for use in dePression bw sinsle 
dailw dosing. Generally, they are administered three or 
four times a daw in divided doses. This would make the 
response at 12 hours a less significant findins than would 
otherwise be the case. Although compliance to dose 
schedules is a well known Problem amons Patients with 
affective disorders and maw arsue for the relevance of the 
12 hour time Point, this maY be dismissed since most 
Published studies with which we draw uPon for establishing 
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the latency to the therapeutic effect have been Performed 
using hospitalized Patients in which comPliance related 
Problems are not significant. 
Failure to demonstrate a greater magnitude 
following multiPle dosing schedules along 
of effect 
with the 
considerations discussed concerning the duration of the 
biochemical e~fect suggest that uptake blockade is not 
temPorallY correlated with the clinical response. 
The alternative hYPotheses regarding elevations in 
serum ionized calcium as a function of tricYclicr thyroid 
hormone or their combined administration also failed to 
receive experimental support using rats. Of the doses and 
durations of administration tested using ProtriPtYline 
and/or tri-iodothYroniner significant differences were not 
demonstrable considering either the Primary response measure 
or any of the secondary variables tested which are known or 
suspected to be reflective of alterations in calcium 
homeostasis. The significant findings of the high dose 
ProtriPtYline experiment <table 4> failed to be confirmed 
when the control group was adJusted for the effects due to 
inanition <table 6). Under conditions in which dietarY 
considerations were not a Problemr as in the theraPeuticallY 
relevant dosage range studied <table 
differences were not discernable. 
7)r significant 
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Although the data fail to confirm an~ of the three 
calcium related h~Pothesesr two arguments ma~ be made in 
defense of the value of the h~Potheses and underscore the 
need for continuing investigation. The clinical data 
demonstrating an effect of tric~clics temPorall~ correlated 
with the therapeutic effect were obtained from depressives. 
There are no generall~ well accepted animal models of 
dePression esPeciall~ in rats. Tric~clicsr unlike Ps~chic 
stimulants, are without such effects in non-depressed 
individuals. Perhaps in order to observe a stimulator~ 
effect of tric~clics upon serum ionized calciumr the 
organism must be depressed. 
The observation of elevated serum ionized calcium among 
h~Perth~roid individualsr who are not depressed, does not 
agree with the findings Presented here using rats. Howeverr 
a recent rePort concerning calcium metabolism in rats 
concludes that bone calcium is not exchangeable with the 
calcium of serum in this species as occurs in dogs or chicks 
<24). For this reason the rat ma~ be considered a Poor 
animal model in which to stud~ the effects of tric~clics 
upon serum ionized calcium. As a result of these 
considerations it 
of antidepressant 
is suggested that the calcium h~Potheses 
action should receive thorough 
investigation within clinicall~ depressed Patients. 
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SUMMARY 
Uptake blockade of norePinePhrine into rat hYPothalamic 
synaPtosomes was studied ex-vivo followins acuter subchronic 
and chronic ProtriPtYline administration. This experiment 
was Performed to determine if multiple dosins results in a 
response which is sreater in masnitude and/or duration than 
observed following acute drug administration in order to 
Sather support for uptake blockade as the Primary mechanism 
of action of tricYclics. The results sussest that multiPle 
dosing does not alter this response measure in such a way as 
to convincingly demonstrate that uptake blockade is the 
Primary mechanism of antidepressant action of tricYclics. 
An alternative hYPothesis concerning the antidepressant 
action of tricYclics and thyroid hormone invokins a role for 
serum ionized calcium was similarly untenable based upon the 
experimental results obtained. ProtriPtYline and/or 
tri-iodothYronine failed to alter serum ionized calcium or 
any of the secondary response measures which are known or 
suspected to be reflective of alterations in calcium 
homeostasis. Support for the calcium hYPothesis was offered 
by emphasizing recently Published data suggesting that rats 
may be a Poor model for studying calcium homeostasis. 
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Table 1 • Effect of ProtriPt':lline (10 ms/ks> Upon Ser•Jm 
Ionized and Total Calcium 
ECa++Jd [CaJe 
a Tosb NC Mean±s.ri. Mean±s.ri. Treatment 
Saline 2 13 .947±.046 2 .188±. 179 
Acute 2 15 .973±.039 2. 246:!:. 198 
S•Jbch ron i c 2 15 .965±.044 2.288±.181 
Chronic 2 14 .969±.038 2.233±.234 
Saline 6 14 1.005±.063 2.073±.110 
Ac•Jte 6 15 1.029±.067 2.080±.119 
S•Jbch ron i c 6 15 1.019±.052 2.078±.089 
Chronic 6 15 1.022±.052 2.019±.125 
Saline 12 8 1.003±.026 2.206±.082 
Acute 12 14 .977±.054 2.251±.128 
Subchronic 12 15 .984±.041 2.253±.140 
Chronic 12 13 .993±.039 2.176±.148 
Saline 24 15 1.010±.026 2.156±.123 
Ac•Jte 24 15 1.012±.035 2.220±.127 
S•Jbch ron i c 24 15 1.016±.027 2.181±.135 
Chronic 24 13 1.010±.041 2.108±.097 
a. Saline: 18 dail':I inJections (i.P.) of saline 
Acute: 17 dail'=I inJections of saline followed b':I 
one inJection of protriPt':lline 
Subchronic: 12 dail'=I inJections of saline 
followed by 6 of ProtriPt':lline 
Chronic: 18 dail':I inJections of ProtriPt':lline 
b. Time of Sacrifice after the last inJectionr in hours 
c. Number of animals 
d. Serum ionized calciumr mH 
e. Total serum calciumr mH 
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Table 2. Effect of Tri-iodoth~ronine Administration 
on Serum Ionized and Total Calcium 
Treatment8 
Saline 
T3 1r000 
Saline 
T3 1r000 
Saline 
T3 1 rOOO 
Saline 
T3 1 rOOO 
Saline 
T3 1 
T3 10 
T3 100 
T3 250 
T3 500 
T3 1r000 
DoAb 
1 
1 
1 
1 
1 
1 
5 
5 
10 
10 
10 
10 
10 
10 
10 
1 
1 
4 
4 
24 
24 
4 
4 
4 
4 
4 
4 
4 
4 
4 
N 
10 
10 
10 
10 
5 
6 
6 
6 
6 
6 
5 
6 
6 
6 
3 
1.021:L048 
1.017±.064 
1.087±.054 
1.074±.056 
1.037±.046 
1.099±.063 
1+119±.011 
1.037±.037 
1.069±.051 
1+078±.029 
1+061±.035 
1.057±.031 
1.006±.088 
1. 047±. 041 
.953±.045 
a. Saline or tri-iodoth~ronine <T 3 > in ug/kg b. Da~s of Administration 
2.298±.138 
2.345±.075 
2+363±.158 
2.425±.049 
2.063±.033 
2+128±.074 
2.211±.088 
2.101±.090 
2+246±.115 
2+156±.101 
2+188±.123 
2.118±.114 
2.006±.140 
2+038±.086 
1.978±.091 
c. Time of Sacrifice after the last doser in hours 
d. Serum ionized calciumr mM <Mean±S.D.> 
e. Total serum calciumr mM <Mean±S.D.> 
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Table 3. The Effect of Concomitant Tri-iodothYronine <T 3 ) 
and ProtriF-tYlir1e <5ms/ks> Administration8 for 14 
Serum 
ResF-onse 
Meas•Jre 
[Cat+J, mM 
[CaJ, mM 
[NaJ, mM 
EKJ, mM 
EClJ, mM 
DaYs UF-on ResF-onse Measures SusF-ected to be 
Reflective of Calcium Homeostasis <Mean±SD,N=6> 
Saline 
Control 
1.26±.12 
2+53±.14 
144.8±1.8 
5.20±.78 
101. 8±3 +1 
10.3±1.3 
7.46±.10 
63.0±15.6 
PRO+T 
<1us/ks> 
1.22±.10 
2.53±.10 
143.9±1.9 
5.76±.90 
99.9±3.4 
13.0±.70 
7.37±.08 
72.6±18.4 
PRO+T PRO+T 
<10us/ks> <100ug/ks> 
2.49±.06 2.35±.30 
144.9±1.4 143.5±1.4 
5.10±.50 5.20±.43 
100.9±2.7 101.8±3+2 
10.7±1.0 10.2±1.3 
7+45±.06 7.42±.09 
58.8±7.5 68.8±11.9 
Glucose 173.3±47.9 179.2±31+2 140.0±14.8 157.5±31.9 
ms/dL 
BUN,rns/dL 21+7±3+3 16.4±2.9 17.5±2.7 16.0±2.1 
Creatinine .58±.11 .54±.07 .39±.14 .36±.20 
1119/dL 
Protein 4+84±.46 4.31±.40 5+92±1.36 6.30±1.40 
s/dL 
Conductivity .090±.002 .090±.002 .091±.002 .091±.004 
<M KCl> 
a. ProtriF-tYline was administered i+P•• whereas T3 was 
siven subcutanea.61Y 
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Table 4. The Effect of a Hish Dose <20ms/ks> of 
ProtrwPtwline Chronicallw Administered <14 da~s> 
on Bodw Weisht, Blood Constituents and Bone 
<mean±S.D., N=10> 
Bodw weisht, sms. 
BLOOD 
[CaJ' n1M 
Protein, s/dL 
Alk. Phos. 
Sisma U/ml 
H~dro~·:w-prol ine 
us/ml 
BONE 
Femur weisht, sms. 
Femur volume, ml 
Femur densitw, s/ml 
Femur calcium densitw, 
nrs/nrl 
Control 
486.2±57.8 
2.22±.19 
7.71±.94 
6.05±.10 
4.75±.84 
1.1651±.1274 
• 746±.076 
1.562±.051 
234.3±14.1 
PRO 
376.0±41.9 
2.02±.37 
7.62±.91 
5.64±.32 
4.33±.77 
3.08±1.59 
1.0750±.0760 
+730±.068 
1.478±.099 
211.4±10.2 
F' 
< .01 
N.S. 
N.S. 
< .01 
N.S. 
N.S. 
N.S • 
N.S. 
< .01 
< .01 
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Table 5A. The Effects of Subchronic <6 days) ProtriPtYline <20ms.ke> Administration 
IndeN 
Bod!:I 
Wei9ht 
<ems> 
Food 
Intake 
< 9ms) 
Water 
Intake 
( ITI 1 ) 
Urine 
out Put 
<ml> 
Fecal 
out Put 
<ems> 
Compared with Weisht AdJusted Controls on Gross Indices of Metabolism 
<means±s.n., N=10> 
DaY 1 [lay 2 Da!:I 3 [lay 4 [lay 5 [lay 6 
289.0±28.7 289.0±35.2 281.3±29.3 275.0±21.6 275.4±21.6 268.7±26.2 
309.2±34.5 300.0±30.2 284.5±12.6 287.Q.±19.2 286.8±20.0 280.7±20.9 
17.5±2.6 5.7±2.2. 5.8±2.8 12.8±3.5 14.3±3.9 13.3±3.7 
10.9±3.3 6.4±1.6 9.6±2.6 11.2±3.0 9.3±2.1 7.9±1.7 
33.3±8.6 25.1±7.2 36.0±4.5 32.3±2.1 36.2±3.2 20.8±7.0 
20.1±5.5 24.7±4.4 29.5±5.4 26.0±5.8 30.4±3.2 26.2±6.3 
8+4±2+2 11.2±3.2 13.6±2.6 12.1±1.9 17.4±2.3 12.2±2.7 
5+7±0.8 4.4±0.7 3.7±1.5 7+1±1.7 13.8±3.2 9.3±1.6 
3.3±0.6 1.4±0.4 1.5±0.2 1.4±0.4 2.4±0.5 1.8±0.4 
2.1±0.5 1.6±0.5 2.20.6 1.6±0.5 1..7±0.4 2.2±0.5 
Trt 
Con 
PRO 
Con 
PRO 
Con 
PRO 
Con 
PRO 
Con 
PRO 
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Table SB. The Effects of Subchronic (6 days) ProtriPtYline (20m9/k9> Administration 
Inde:·: 
Calcium 
output 
(ms> 
HYdro:·:Y-
r-,rol ine 
( IJmO 1) 
Ma9nesium 
output 
<mmol> 
Phosphate 
out Put 
<mmol) 
Creatinine 
outPut 
<mmol) 
Compared with Weisht AdJusted Controls on Urinary Indices of Calcium 
Metabolism <mean±S.D., N=10> 
Day 1 Day 2 DaY 3 Da!:I 4 Day 5 [lay 6 
.383±.225 .235±.109 .243±.1.32 .241±.:1.04 .255±.184 .241±.135 
.251±.192 .123±.085 .155±.156 .203±.123 • 225:!:. 111 .204±.046 
8.9f2.4 9.2f3.6 9.0+4.4 7.6+4.3 10.4+3.8 a.2+2.7 
8.6±1.6 9.0±3.1 10.2±6.5 9.4±3.6 10.9±3.B 9.6±2.5 
.074±.065 .060±.048 .032±.028 .037±.016 .047±.036 .039±.027 
.057±.038 .035±.021 .033±.036 .041±.030 .089±.143 .043±.030 
.527±.174 .525±.155 .499±.199 .551±.266 .587±.182 .509±.208 
.581±.163 .475±.172 .414±.306 .586±.435 .932±.314 .586±.166 
.057±.025 .055±.023 .049±.030 .065±.030 .059±.021 .055±.019 
.055±.015 .059±.018 .056±.035 .070±.034 .120±.057 .053±.016 
Trt 
Con 
PRO 
Con 
PRO 
Con 
PRO 
Con 
PRO 
Con 
PRO 
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Table 6. The Effect of a High Dose <20mg/kg) of 
ProtriPt~line Subchronicall~ Administered 
<6 da~s> on Blood Constituents and Bone 
<mean±S.D., N=lO>. 
BLOOD 
[Cat+J, mM 
[CaJ, mM 
[MgJ, mM 
AH. . F'hos. 
Sisma U/ml 
CF'K 
Sigma U/ml 
Protein, 9/dL 
BONE 
Femur weight, gms. 
Femur vol1J1rre' ml 
Femur densit~, g/ml 
Weight AdJ•Jsted 
Controls 
1.17±.13 
1.73±.31 
8.31±.66 
1.18±.03 
5. 33±1. 30 
26.11±8.27 
5.69±.43 
.7536±.0533 
.533+.044 
1.416±.0334 
PRO 
1.13±.11 
1.65±.11 
7.99±1.71 
1.19±.06 
3.38±1.33 
25.70±11.96 
4.98±.76 
.7605±.0450 
.544+.039 
1.3998±.0461 
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Table 7. The Effect of TheraPeuticall~ Relevant Doses 
of ProtriPt~line <0.5ms/ks> and ImiPramine 
<5.0ms/ks> Administered Subchronicall~ (6 da~s) 
on Blood Constituents and Bone (mean±S.D., N=10> 
Control PRO IMI 
BLOOD 
[Cat+J, mM 1.21±.09 1.20±.11 1.19±.10 
[CaJ, mM 1.84±.29 1.85±.34 1.84±.25 
[F'04 --] , mEG/L 8.95±1.08 8.81±1.16 8.44±.87 
[MgJ, mM 1.15±.04 1.16±.02 1.16±.02 
AH . • Phos. 6.73±.94 6.81±2.0 5.76±1.6 
Sisma U/ml 
CPK 30.55±12.5 26.72±.82 32.83±18.1 
Sisma U/ml 
Protein' S/dl 5.65±.55 5.82±.85 5.00±.01 
BONE 
Femur weisht, sms. .7883±.0406 .8003±.0392 .7660±.0484 
Femur volume' ml .561±.041 .567±.029 .547±.033 
Fem•Jr dens it~, S/ml 1.4133±.0595 1.4120±.0378 1+4190±.0344 
ElGURE 1 
LEGE~D 
ElGU~E 2 
LEGE~D 
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TITLE: The effect of ether administration on 
3H-norePinePhrine uptake into rat 
h~Pothalamic s~naPtosomes 
Depicted are the means and standard deviations 
of five determinations. SIC = saline inJected 
controls; PR0-10 = protriPt~line C10mg/kg) 
Siven 6 hours Prior to sacrifice. 
TITLE: The effects of acute, subchronic and 
chronic ProtriPt~line administration 
upon the uPtake of 3H-norePinePhrine 
into rat h~Pothalamic s~naPtosomes 
Depicted are the means and standard deviations 
of five separate determinations. 
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